SP1 and ovarian carcinoma: It has been observed that hsa-miR-335-5p acts as a tumor suppressor when it targets Bcl-w in ovarian cancer cell lines [34] or SP1 and Bcl-w in GC, where it suppresses cell invasion but not proliferation [35].